Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-440-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09 April 2018 - 06 June 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- Version / remarks:
- 29 July 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
Test material
- Reference substance name:
- Esterification products of acrylic acid with reaction products of 2,2-dimethylpropane-1,3-diol and methyloxirane
- EC Number:
- 701-440-2
- Molecular formula:
- (C3H6O)x (C3H6O)y C11H16O4
- IUPAC Name:
- Esterification products of acrylic acid with reaction products of 2,2-dimethylpropane-1,3-diol and methyloxirane
- Test material form:
- liquid
1
Method
- Target gene:
- Not applicable (not a gene mutation assay).
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: RPMI 1640 medium containing 10% inactivated horse serum, L-Glutamine (2 mM), penicillin (100 U/mL), streptomycin (100 µg/mL) and sodium pyruvate (200 µg/mL)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes - Additional strain / cell type characteristics:
- not applicable
- Cytokinesis block (if used):
- n/a
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 mix
- Test concentrations with justification for top dose:
- Since the test item was found to be severely cytotoxic in the preliminary tests, the highest dose levels selected for the main experiments were based on the level of cytotoxicity, according to the criteria specified in the international regulations.
Experiment without S9 mix
With a treatment volume of 1% (v/v) in culture medium, the dose levels selected for the 3- and 24-hour treatments were 0.63, 1.3, 2.5, 3.8, 5, 7.5, 10 and 15 µg/mL.
Experiments with S9 mix
With a treatment volume of 1% (v/v) in culture medium, the dose levels selected for the treatments were as follows:
- 6.3, 12.5, 25, 37.5, 50, 75, 100 and 150 µg/mL in the first experiment,
- 0.781, 1.17, 1.56, 2.34, 3.13, 4.69, 6.25, 9.38, 12.5, 18.8, 25, 37.5, 50, 75, 100 and 150 µg/mL in the second experiment. - Vehicle / solvent:
- - Vehicle used: dimethylsulfoxide (DMSO)
- Justification for choice:
Using a test item concentration of 500 mg/mL in the vehicle (DMSO) and a treatment volume of 1% (v/v) in culture medium, the highest recommended dose level of 5000 µg/mL was achievable. Thus, the dose levels selected for the treatment of the first preliminary test were 20.58, 61.73, 185.2, 555.6, 1667 and 5000 µg/mL.
Using a test item concentration of 10 mg/mL in DMSO and a treatment volume of 1% (v/v) in culture medium, the dose levels selected for the treatment of the second preliminary test were 0.20, 0.39, 0.78, 1.56, 3.13, 6.25, 12.5 and 25 µg/mL in the absence of S9 mix and 0.78, 1.56, 3.13, 6.25, 12.5, 25, 50 and 100 µg/mL in the presence of S9 mix.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Mitomycin C, colchicine (-S9 mix); cyclophosphamide (+S9 mix)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION:
Preliminary cytotoxicity test
Without S9 mix
3 h treatment + 24 h recovery
24 h treatment + 0 h recovery
With S9 mix
3 h treatment + 24 h recovery
Main cytogenetic experiments
Without S9 mix
3 h treatment + 24 h recovery
24 h treatment + 0 h recovery
With S9 mix
3 h treatment + 24 h recovery
NUMBER OF CELLS EVALUATED: 2000/dose
DETERMINATION OF CYTOTOXICITY
- Method: population doubling - Evaluation criteria:
- The biological relevance of the results was always taken into account when evaluating results.
Evaluation of a positive response: a test item is considered to have clastogenic and/or aneugenic potential, if all the following criteria were met:
- a dose-related increase in the frequency of micronucleated cells was demonstrated by a statistically significant trend test,
-for at least one dose level, the frequency of micronucleated cells of each replicate culture was above the corresponding vehicle historical range,
- a statistically significant difference in comparison to the corresponding vehicle control was obtained at one or more dose levels.
Evaluation of a negative response: a test item is considered clearly negative if none of the criteria for a positive response was met. - Statistics:
- For each condition of the cytogenetic experiment, the frequency of micronucleated cells in treated cultures was compared to that of the vehicle control cultures.
This comparison was performed using the Khi2 test, unless treated culture data are lower than or equal to the vehicle control data. P = 0.05 was used as the lowest level of significance. This statistical analysis was performed using a validated Excel sheet.
To assess the dose-response trend, a linear regression was performed between the frequencies of micronucleated cells and the dose levels. This statistical analysis was performed using SAS Enterprise Guide software.
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: none
- Effects of osmolality: none
- Precipitation: none
RANGE-FINDING STUDIES:
Using a test item concentration of 500 mg/mL in the vehicle (DMSO) and a treatment volume of 1% (v/v) in culture medium, the highest recommended dose level of 5000 µg/mL was achievable. Thus, the dose levels selected for the treatment of the first preliminary test were 20.58, 61.73, 185.2, 555.6, 1667 and 5000 µg/mL.
At the highest dose level of 5000 µg/mL, the pH of the culture medium was approximately 7.4 (as for the vehicle control) and the osmolality was 361 mOsm/kg H2O (447 mOsm/kg H2O for the vehicle control). Therefore, none of the selected dose levels was considered to produce extreme culture conditions.
An emulsion was observed in the culture medium at dose levels >= 555.6 µg/mL, at the end of both treatment periods.
Following the 3- and 24-hour treatments without S9 mix, a severe cytotoxicity was observed at all from the lowest dose levels (i.e. from 20.58 µg/mL), as shown by a 100% decrease in the PD (Table 1).
Following the 3-hour treatment with S9 mix, a moderate to severe cytotoxicity was observed from the lowest dose levels of 20.58 µg/mL, as shown by a 48 to 100% decrease in the PD.
NUMBER OF CELLS WITH MICRONUCLEI:
- Number of cells for each treated and control culture: see Tables enclosed.
- Indication whether binucleate or mononucleate where appropriate: mononucleates cells 'L5178Y
cell line).
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%): see document attached.
RESULTS OF CYTOTOXICITY:
Since the test item was found to be severely cytotoxic in the preliminary tests, the highest dose levels selected for the main experiments were based on the level of cytotoxicity, according to the criteria specified in the international regulations.
The mean population doubling and the mean frequencies of micronucleated cells for the vehicle controls were as specified in the acceptance criteria. Also, positive control cultures showed clear statistically significant increases in the frequency of micronucleated cells. The study was therefore considered to be valid.
First of all, no emulsion was observed in the culture medium at any dose levels, at the end of both treatment periods in either main experiment.
Experiment without S9 mix:
With a treatment volume of 1% (v/v) in culture medium, the dose levels selected for the 3- and 24-hour treatments were 0.63, 1.3, 2.5, 3.8, 5, 7.5, 10 and 15 µg/mL.
Cytotoxicity:
Following the 3- and 24-hour treatments, a 40 to 100% decrease in the PD was induced at dose levels = 2.5 µg/mL (Tables 3 and 5).
Micronucleus analysis:
The dose levels selected for the micronucleus analysis were as follows:
- 0.63, 1.3 and 2.5 µg/mL for the 3-hour treatment, the latter inducing a 50% decrease in the PD (i.e. the recommended level of cytotoxicity of 55 ± 5% cytotoxicity),
- 0.63, 1.3 and 2.5 µg/mL for the 24-hour treatment, the latter inducing only a 40% decrease in the PD but higher dose levels being too cytotoxic.
Following the 3- or 24-hour treatments without S9 mix, neither statistically significant nor dose-related increase in the frequency of micronucleated cells was noted at any of the analyzed dose levels in comparison to the corresponding vehicle control (Tables 4 and 6; p>0.05). Moreover, none of the analyzed dose levels showed frequency of micronucleated cells of both replicate cultures above the corresponding vehicle control historical range.
Following the 24-hour treatment, none of the selected dose levels induced the recommended level of cytotoxicity. Nevertheless, considering the narrow dose levels spacing used in this experimental condition, the available results were considered as suitable to allow a reliable interpretation. These results without S9 mix are thus considered to meet the criteria of a negative response.
Experiments with S9 mix:
With a treatment volume of 1% (v/v) in culture medium, the dose levels selected for the treatments were as follows:
- 6.3, 12.5, 25, 37.5, 50, 75, 100 and 150 µg/mL in the first experiment,
- 0.781, 1.17, 1.56, 2.34, 3.13, 4.69, 6.25, 9.38, 12.5, 18.8, 25, 37.5, 50, 75, 100 and 150 µg/mL in the second experiment.
Cytotoxicity:
A 68 to 100% decrease in the PD was induced at dose levels = 12.5 µg/mL in the first experiment (Table 7).
A 46 to 100% decrease in the PD was induced at dose levels = 12.5 µg/mL in the second experiment (Table 8).
Micronucleus analysis:
Since not enough analyzable dose levels were obtained in the first experiment with S9 mix due to the high cytotoxicity of the test item, the corresponding micronucleus analysis was not performed.
In the second experiment, the dose levels selected for the micronucleus analysis were 4.69, 9.38 and 25 µg/mL, the latter inducing a 49% decrease in the PD and higher dose levels being too cytotoxic.
Following the 3-hour treatment with S9 mix, neither statistically significant nor dose-related increase in the frequency of micronucleated cells was noted at any of the analyzed dose levels in comparison to the vehicle control (Table 9; p>0.05). Moreover, none of the analyzed dose levels showed frequency of micronucleated cells above the corresponding vehicle control historical range.
None of the selected dose levels induced the recommended level of cytotoxicity, however the values are near to the recommended level of cytotoxicity (49 vs 55 ± 5%). Nevertheless, the values are close to the recommended level of cytotoxicity (up to 49% versus 55 ± 5%) and considering the narrow dose levels spacing used in this experimental condition, the available results were considered as suitable to allow a reliable interpretation. These results with S9 mix are thus considered to meet the criteria of a negative response.
Applicant's summary and conclusion
- Conclusions:
- Under the experimental conditions of the study, the test item did not induce any chromosome damage, or damage to the cell division apparatus, in cultured mammalian somatic cells, using L5178Y TK+/- mouse lymphoma cells, either in the presence or absence of a rat liver metabolizing system.
- Executive summary:
The objective of this study was to evaluate the potential of the test item to induce an increase in the frequency of micronucleated cells in the mouse cell line L5178Y TK+/-.
The study was performed according to the international guidelines and in compliance with the principles of Good Laboratory Practice.
Methods
After two preliminary cytotoxicity tests, the test item, diluted in dimethylsulfoxide (DMSO) was tested in two independent experiments with and without a metabolic activation system, the S9 mix, prepared from a liver microsomal fraction (S9 fraction) of rats induced with Aroclor 1254, as follows:
First experiment
Second experiment
Without S9 mix
3 h treatment + 24 h recovery
-
24 h treatment + 0 h recovery
-
With S9 mix
3 h treatment + 24 h recovery
3 h treatment + 24 h recovery
Each treatment was coupled to an assessment of cytotoxicity at the same dose levels. Cytotoxicity was evaluated by determining the PD (Population Doubling) of cells.
After the final cell counting, the cells were washed and fixed. Then, when applicable (i.e. when enough analyzable dose levels were obtained), cells from at least three dose levels of the test item-treated cultures were dropped onto clean glass slides. The slides were air-dried before being stained in 5% Giemsa. Slides from vehicle and positive controls cultures were also prepared as described above. All slides were coded before analysis, so that the analyst was unaware of the treatment details of the slide under evaluation ("blind" scoring). When the slide analysis was undertaken, micronuclei were analyzed for three dose levels of the test item, for the vehicle and the positive controls, in a total of 2000 mononucleated cells per dose.
Number of cells with micronuclei and number of micronuclei per cell were recorded separately for each treated and control culture.
Results
Since the test item was found to be severely cytotoxic in the preliminary tests, the highest dose levels selected for the main experiments were based on the level of cytotoxicity, according to the criteria specified in the international regulations.
The mean population doubling and the mean frequencies of micronucleated cells for the vehicle controls were as specified in the acceptance criteria. Also, positive control cultures showed clear statistically significant increases in the frequency of micronucleated cells. The study was therefore considered to be valid.
First of all, noemulsionwas observed in the culture medium at any dose levels, at the end of both treatment periods in either main experiment.
Experiment without S9 mix
With a treatment volume of 1% (v/v) in culture medium, the dose levels selected for the 3- and 24-hour treatments were 0.63, 1.3, 2.5, 3.8, 5, 7.5, 10 and 15 µg/mL.
Cytotoxicity
Following the 3- and 24-hour treatments, a 40 to 100% decrease in the PD was induced at dose levels = 2.5 µg/mL.
Micronucleus analysis
The dose levels selected for the micronucleus analysis were as follows:
. 0.63, 1.3 and 2.5 µg/mL for the 3-hour treatment, the latter inducing a 50% decrease in the PD (i.e. the recommended level of cytotoxicity of 55 ± 5% cytotoxicity),
. 0.63, 1.3 and 2.5 µg/mLfor the 24-hour treatment,the latter inducing only a 40% decrease in the PD but higher dose levels being too cytotoxic.
Following the 3- or 24-hour treatments without S9 mix, neither statistically significant nor dose-related increase in the frequency of micronucleated cells was noted at any of the analyzed dose levels in comparison to the corresponding vehicle control. Moreover, none of the analyzed dose levels showed frequency of micronucleated cells of both replicate cultures above the corresponding vehicle control historical range.
Following the 24-hour treatment, none of the selected dose levels induced the recommended level of cytotoxicity. Nevertheless, considering the narrow dose levels spacing used in this experimental condition, the available results were considered as suitable to allow a reliable interpretation. These results without S9 mix are thus considered to meet the criteria of a negative response.
Experiments with S9 mix
With a treatment volume of 1% (v/v) in culture medium, the dose levels selected for the treatments were as follows:
. 6.3, 12.5, 25, 37.5, 50, 75, 100 and 150 µg/mL in the first experiment,
. 0.781, 1.17, 1.56, 2.34, 3.13, 4.69, 6.25, 9.38, 12.5, 18.8, 25, 37.5, 50, 75, 100 and 150 µg/mL in the second experiment.
Cytotoxicity
A 68 to 100% decrease in the PD was induced at dose levels = 12.5 µg/mL in the first experiment.
A 46 to 100% decrease in the PD was induced at dose levels = 12.5 µg/mL in the second experiment.
Micronucleus analysis
Since not enough analyzable dose levels were obtained in the first experiment with S9 mix due to the high cytotoxicity of the test item, the corresponding micronucleus analysis was not performed.
In the second experiment, the dose levels selected for the micronucleus analysis were 4.69, 9.38 and 25 µg/mL, the latter inducing a 49% decrease in the PD and higher dose levels being too cytotoxic.
Following the 3-hour treatment with S9 mix, neither statistically significant nor dose-related increase in the frequency of micronucleated cells was noted at any of the analyzed dose levels in comparison to the vehicle control. Moreover, none of the analyzed dose levels showed frequency of micronucleated cells above the corresponding vehicle control historical range.
None of the selected dose levels induced the recommended level of cytotoxicity. Nevertheless, the values are close to the recommended level of cytotoxicity (up to 49% versus 55 ± 5%) and considering the narrow dose levels spacing used in this experimental condition, the available results were considered as suitable to allow a reliable interpretation. These results with S9 mix are thus considered to meet the criteria of a negative response.
Conclusion
Under the experimental conditions of the study, the test item did not induce any chromosome damage, or damage to the cell division apparatus, in cultured mammalian somatic cells, using L5178Y TK+/-mouse lymphoma cells, either in the presence or absence of a rat liver metabolizing system.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.